Janus Henderson Group’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-102,349
| Closed | -$219K | – | 2481 |
|
|
2024
Q4 | $219K | Hold |
102,349
| – | – | ﹤0.01% | 2397 |
|
|
2024
Q3 | $287K | Hold |
102,349
| – | – | ﹤0.01% | 2291 |
|
|
2024
Q2 | $238K | Buy |
102,349
+65,851
| +180% | +$153K | ﹤0.01% | 2318 |
|
|
2024
Q1 | $163K | Hold |
36,498
| – | – | ﹤0.01% | 2459 |
|
|
2023
Q4 | $117K | Buy |
36,498
+25
| +0.1% | +$80 | ﹤0.01% | 2516 |
|
|
2023
Q3 | $116K | Buy |
36,473
+71
| +0.2% | +$225 | ﹤0.01% | 2493 |
|
|
2023
Q2 | $180K | Sell |
36,402
-31
| -0.1% | -$154 | ﹤0.01% | 2474 |
|
|
2023
Q1 | $180K | Buy |
36,433
+20,596
| +130% | +$102K | ﹤0.01% | 2519 |
|
|
2022
Q4 | $99.5K | Sell |
15,837
-15,839
| -50% | -$99.6K | ﹤0.01% | 2334 |
|
|
2022
Q3 | $342K | Buy |
31,676
+15,603
| +97% | +$168K | ﹤0.01% | 2129 |
|
|
2022
Q2 | $184K | Buy |
16,073
+426
| +3% | +$4.88K | ﹤0.01% | 2332 |
|
|
2022
Q1 | $143K | Buy |
+15,647
| New | +$143K | ﹤0.01% | 2508 |
|
|
2021
Q4 | – | Sell |
-7,795
| Closed | -$200K | – | 2545 |
|
|
2021
Q3 | $200K | Buy |
+7,795
| New | +$200K | ﹤0.01% | 2081 |
|